BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25483211)

  • 1. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-prolyl hydroxylase is a potential molecular target for esculetin-mediated anti-colitic effects.
    Yum S; Jeong S; Lee S; Kim W; Nam J; Jung Y
    Fitoterapia; 2015 Jun; 103():55-62. PubMed ID: 25797536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-Mercaptopropionyl)-glycine, a diffusible antioxidant, activates HIF-1 by inhibiting HIF prolyl hydroxylase-2: implication in amelioration of rat colitis by the antioxidant.
    Yum S; Park H; Hong S; Jeong S; Kim W; Jung Y
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1008-13. PubMed ID: 24361888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase.
    Yum S; Doh HJ; Hong S; Jeong S; Kim DD; Park M; Jung Y
    Eur J Pharmacol; 2013 Jan; 699(1-3):124-31. PubMed ID: 23261967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
    Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
    Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase.
    Yum S; Jeong S; Kim D; Lee S; Kim W; Yoo JW; Kim JA; Kwon OS; Kim DD; Min DS; Jung Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication.
    Choi D; Han J; Lee Y; Choi J; Han S; Hong S; Jeon H; Kim YM; Jung Y
    J Nutr Biochem; 2010 Sep; 21(9):809-17. PubMed ID: 19740641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.
    Hong S; Yum S; Ha NC; Jung Y
    Anal Biochem; 2010 Dec; 407(2):220-5. PubMed ID: 20705044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosmarinic Acid Methyl Ester Inhibits LPS-Induced NO Production via Suppression of MyD88- Dependent and -Independent Pathways and Induction of HO-1 in RAW 264.7 Cells.
    So Y; Lee SY; Han AR; Kim JB; Jeong HG; Jin CH
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27548124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors.
    Thirstrup K; Christensen S; Møller HA; Ritzén A; Bergström AL; Sager TN; Jensen HS
    Pharmacol Res; 2011 Sep; 64(3):268-73. PubMed ID: 21504793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constituents of Mediterranean Spices Counteracting Vascular Smooth Muscle Cell Proliferation: Identification and Characterization of Rosmarinic Acid Methyl Ester as a Novel Inhibitor.
    Liu R; Heiss EH; Waltenberger B; Blažević T; Schachner D; Jiang B; Krystof V; Liu W; Schwaiger S; Peña-Rodríguez LM; Breuss JM; Stuppner H; Dirsch VM; Atanasov AG
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700860. PubMed ID: 29405576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of hypoxia-induced HIF-1α signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor.
    Deppe J; Popp T; Egea V; Steinritz D; Schmidt A; Thiermann H; Weber C; Ries C
    Arch Toxicol; 2016 May; 90(5):1141-50. PubMed ID: 26082309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
    Lee SH; Bae SC; Kim KW; Lee YM
    Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.